| Oct 4 |
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
|
| Oct 4 |
Texas sues major PBMs, pharma companies over high insulin prices
|
| Oct 1 |
Update: Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
|
| Oct 1 |
Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
|
| Oct 1 |
Sanofi Is Said to Ask Bidders to Revise Consumer Health Offers
|
| Sep 30 |
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
|
| Sep 28 |
Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
|
| Sep 27 |
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
|
| Sep 27 |
Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
|
| Sep 27 |
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
|
